Prices delayed by at least 15 minutes | Print


Edwards Lifesciences Corp (EW)

Common Stock
Sell: $85.48|Buy: $90.69|Change: 0.79 (-0.91%)

Open 

$87.35


Previous close 

$87.24


Trade high 

$87.35


Volume 

3,122,037


Year high 

$96.12


Year low 

$60.57


Dividend yield 

-


Market capitalisation 

$52.04 bn


P/E ratio 

37.93


ISIN 

US28176E1082


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Performance 18/04/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Edwards Lifesciences Corp- 0.91
More...

Company profile

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.